UK’s AstraZeneca completes acquisition of SixPeaks Bio to advance next-gen obesity treatments

The strange thing is not that some people reply quickly. Most of us do, at least when the message is...

Institutional investing has long operated on a simple but costly constraint: research capacity scales with headcount, and headcount scales slowly....

There is a familiar scene in families after retirement. A man who once spoke fluently about deadlines, machinery, customers, colleagues...

Most “communities” launched by startups are dead within a year. Not because community-led growth doesn’t work, but because of how...

Your ads are doing their job. People are clicking, visiting your website, and even adding products to their cart, but...

New York City startups raised $8.88 billion across 233 deals in Q2 2026 — a 46% year-over-year surge in capital...